Back to Results
First PageMeta Content
Membrane biology / Transient receptor potential cation channel / member A1 / Cubist Pharmaceuticals / Pain management / Hypertension / TRPA / Medicine / Biology / Ion channels


Microsoft Word - Hydra-CubistpressreleaseFINAL.doc
Add to Reading List

Document Date: 2009-10-19 16:15:30

Open Document

File Size: 12,26 KB

Share Result on Facebook

City

CAMBRIDGE / /

Company

Hydra Biosciences Hydra Biosciences / Hydra Biosciences / Cubist Pharmaceuticals Inc. / /

Currency

USD / /

Event

Business Partnership / /

IndustryTerm

pharmaceutical sales / biopharmaceutical / pain management / /

MedicalCondition

cardiovascular and other diseases / hypertension / disease / cardiac arrhythmias / pain / diseases / angina / pulmonary diseases / cystic fibrosis / inflammation / gastrointestinal disorders / disorders / /

MedicalTreatment

Pain Management / /

OperatingSystem

Hydra / /

Person

Russell Herndon / Steven Gilman / /

Position

Chief Scientific Officer / Chief Executive Officer / /

ProvinceOrState

Massachusetts / /

URL

www.hydrabiosciences.com / /

SocialTag